NCCN Practice Guidelines for Prostate Cancer.

R. R. Bahnson; G. E. Hanks; R. P. Huben; P. Kantoff; J. M. Kozlowski; M. Kuettel; P. H. Lange; C. Logothetis; J. M. Pow-Sang; M. Roach; H. Sandler; P. T. Scardino; R. J. Taylor; D. A. Urban; P. C. Walsh; T. G. Wilson

NCCN Practice Guidelines for Prostate Cancer.

R. R. Bahnson, G. E. Hanks, R. P. Huben, P. Kantoff, J. M. Kozlowski, M. Kuettel, P. H. Lange, C. Logothetis, J. M. Pow-Sang, M. Roach, H. Sandler, P. T. Scardino, R. J. Taylor, D. A. Urban, P. C. Walsh, T. G. Wilson

Research output: Contribution to journal › Article › peer-review

55 Scopus citations

Abstract

Systemic therapies for prostate cancer are likely to improve, and as they do, they will have enormous impact on the treatment of high-risk and locally advanced cancers. Further technical improvements in radiotherapy and alternative local modalities, such as cryoablation, are also likely, and will bring even more options for local control. It is certain these guidelines will continue to evolve.

Original language	English (US)
Pages (from-to)	111-119
Number of pages	9
Journal	Oncology (Williston Park, N.Y.)
Volume	14
Issue number	11 A
State	Published - Nov 2000
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

Cite this

@article{6b847df8cb0241cf8c579f1caf71be10,

title = "NCCN Practice Guidelines for Prostate Cancer.",

abstract = "Systemic therapies for prostate cancer are likely to improve, and as they do, they will have enormous impact on the treatment of high-risk and locally advanced cancers. Further technical improvements in radiotherapy and alternative local modalities, such as cryoablation, are also likely, and will bring even more options for local control. It is certain these guidelines will continue to evolve.",

author = "Bahnson, {R. R.} and Hanks, {G. E.} and Huben, {R. P.} and P. Kantoff and Kozlowski, {J. M.} and M. Kuettel and Lange, {P. H.} and C. Logothetis and Pow-Sang, {J. M.} and M. Roach and H. Sandler and Scardino, {P. T.} and Taylor, {R. J.} and Urban, {D. A.} and Walsh, {P. C.} and Wilson, {T. G.}",

year = "2000",

month = nov,

language = "English (US)",

volume = "14",

pages = "111--119",

journal = "Oncology (Williston Park, N.Y.)",

issn = "0890-9091",

publisher = "UBM Medica Healthcare Publications",

number = "11 A",

}

TY - JOUR

T1 - NCCN Practice Guidelines for Prostate Cancer.

AU - Bahnson, R. R.

AU - Hanks, G. E.

AU - Huben, R. P.

AU - Kantoff, P.

AU - Kozlowski, J. M.

AU - Kuettel, M.

AU - Lange, P. H.

AU - Logothetis, C.

AU - Pow-Sang, J. M.

AU - Roach, M.

AU - Sandler, H.

AU - Scardino, P. T.

AU - Taylor, R. J.

AU - Urban, D. A.

AU - Walsh, P. C.

AU - Wilson, T. G.

PY - 2000/11

Y1 - 2000/11

N2 - Systemic therapies for prostate cancer are likely to improve, and as they do, they will have enormous impact on the treatment of high-risk and locally advanced cancers. Further technical improvements in radiotherapy and alternative local modalities, such as cryoablation, are also likely, and will bring even more options for local control. It is certain these guidelines will continue to evolve.

AB - Systemic therapies for prostate cancer are likely to improve, and as they do, they will have enormous impact on the treatment of high-risk and locally advanced cancers. Further technical improvements in radiotherapy and alternative local modalities, such as cryoablation, are also likely, and will bring even more options for local control. It is certain these guidelines will continue to evolve.

UR - http://www.scopus.com/inward/record.url?scp=0034327588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034327588&partnerID=8YFLogxK

M3 - Article

C2 - 11195405

AN - SCOPUS:0034327588

SN - 0890-9091

VL - 14

SP - 111

EP - 119

JO - Oncology (Williston Park, N.Y.)

JF - Oncology (Williston Park, N.Y.)

IS - 11 A

ER -

NCCN Practice Guidelines for Prostate Cancer.

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this